medigraphic.com
ISSN 1561-2937 (Print)

2019, Number 1

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2019; 25 (1)

Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

Aldama PLI, Hernández NM, Cuba RAL, Naranjo DAA, Aroche AR, Martínez JO

Language: Spanish
References: 18
Page:
PDF size: 1148.62 Kb.


ABSTRACT

Introduction: Injuries in the left coronary artery, are the presenting worse prognosis, because of the extensive infarct to undertake.
Objective: to characterize diagnosed patients with unprotected left coronary artery disease treated by percutaneous coronary interventionism in the CIMEQ between 2014 and 2016.
Method: Longitudinal and prospective observational study in patients with injury ≥ 50% on left coronary artery, diagnosed by coronary angiography. Is studied the entire universe expressed as inclusion criteria and exclusion corresponding 20 patients. Was used descriptive statistics basic.
Results: the average age in patients studied was 68,5 ± 7,4 years, predominantly males (64, 7%). The cardiovascular risk factors higher prevalence were hypertension (60%) and diabetes mellitus (40%). Dyslipidemia and smoking accounted for 35%. In 65% of cases was used the path radial. 70% of patients presented score syntax low. Is complications Peri proceed in 15% of patients and mortality the two years was 5%.
Conclusions: the majority of patients treated corresponded to the male and ages above female. The path radial was more used. The complexity anatomical predominant expressed by the score syntax corresponded to the first tertil. One-third of patients not suffered complications Peri proceed and mortality follow-up to two years was considered low.


REFERENCES

  1. Cuba. Ministerio de Salud Pública. Dirección Nacional de Estadística. Anuario Estadístico de Salud [Internet]. La Habana: MINSAP; 2015 [citado 11 Abr 2018]. Disponible en: www.sld.cu/sitios/dne.

  2. Fernández, A. Fisiopatología de la angina inestable. Papel de la rotura y trombosis de la placa aterosclerótica. Rev Esp Cardiología 1999; 52 (supl 1): 3 -12.

  3. Takaro T, Pifarre R, Fish R. Veterans Administration Cooperative Study of medical versus surgical treatment for stable angina progress report. Section Left main coronary artery disease. Prog Cardiovasc Dis. 1985; 28:229–34.

  4. Chieffo A, Hildick-Smith D. The European Bifurcation Club Left Main Study (EBC MAIN): rationale and design of an international, multi centre, randomised comparison of two stents strategies for the treatment of left main coronary bifurcation disease. EuroIntervention 2016; 12:47–52.

  5. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, P. Banning A, Benedetto U, Byrne RA, Collet JP, Falk V. Guía ESC/EACTS 2018 sobre revascularización miocárdica. Rev Esp Cardiol. 2019; 72(1):73.e1-e102.

  6. Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. JACC. 2017;69(17):2212.

  7. Naranjo A, Aroche R, Hernández M, Obregón Á, Aldama L. Variabilidad Interobservador del Score SYNTAX en pacientes con diagnóstico de Enfermedad Arterial Coronaria Multivaso. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2018;24(2):14.

  8. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Journal of the American College of Cardiology. 2018:25285

  9. Lee PH, Ahn JM, Chang M, Baek S, Yoon SH, Kang SJ, et al. Left Main Coronary Artery Disease. Secular Trends in Patient Characteristics, Treatments, and Outcomes. JACC 2016; 68 (11): 1233-1246.

  10. Farooq V, Head SJ, Kappetein AP. Widening clinical applications of the SYNTAX score. Heart. 2014;100(4):276-87.

  11. Leguizamón J, Azzari F, Schipani G, Chambre D, Brieva S, Fernández A, et al. Angioplastia del tronco de la arteria coronaria izquierda no protegido en pacientes con alto riesgo quirúrgico. REV ARGENT CARDIOL 2008; 76:93-99.

  12. Madeira S, Raposo L, Brito J, Rodrigues R, Gonçalves P, Teles R, Gabriel H, Machado F, Almeida M, Mendes M. Potential Utility of the SYNTAX Score 2 in Patients Undergoing Left Main Angioplasty. Arq Bras Cardiol. 2016; 106(4):270-278

  13. Negreiros de Andrade PJ, de Alencar Araripe Falcão JL, de Alencar Araripe Falcão B, Lima Rocha HA. Stent versus Coronary Artery Bypass Surgery in Multi-Vessel and Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Trials with Subgroups Evaluation. Arq Bras Cardiol. 2018; [online]. Doi: 10.5935/abc.20190027.

  14. Rodríguez Blanco S, Almeida Gómez J. Angioplastia percutánea con stent en el tronco principal de la arteria coronaria izquierda. CorSalud 2012 Oct-Dic;4(4):266-271.

  15. Serrador Frutos AM, Jiménez-Quevedo P, Pérez de Prado A, Álvarez-Ossorio MP. Registro Español de Hemodinámica y Cardiología Intervencionista. XXVI Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2016) Rev Esp Cardiol. 2017;70(12):1110–1120

  16. Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, et al for the EXCEL Trial Investigators. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med 2016;375:2223-35.

  17. Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IBA, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 2016; 388: 2743–52.

  18. Morice MC, Serruys PW, Kappetein AP, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial. Circulation 2014; 129: 2388-94.




2020     |     www.medigraphic.com